34
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Clinical Manifestations of Recurrent Parotid Pleomorphic Adenoma

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objectives

          This study was undertaken to confirm the clinical characteristics of recurrent pleomorphic adenoma (RPA), and to identify those factors that affect the development of malignant transformation (MT) from RPA.

          Methods

          The medical records of 270 patients, who were operated upon for parotid PA, were retrospectively reviewed. The pathologic specimens of a selected series of 23 patients were reviewed for histologic subtype and microscopic multi-nodularity.

          Results

          Mean age of initial operation in RPA without MT (RPA -MT) group was significantly lower than that of primary PA group. Mean age of the revision operation in RPA with MT (RPA +MT) group was significantly greater than that of RPA -MT group. Mean interval from operation to recurrence shortened after each revision operation. The risk of MT and additional recurrence increased significantly with recurrence. In RPA -MT group tumor recurrence occurred in 21.4% of patients despite a clear resection margin.

          Conclusion

          The risk factors for MT may be an age of over 45 yr and multiple recurrences. However, younger patients are more at risk of recurrence. A clear resection margin cannot guarantee a cure in RPA, and it seems that parotid pleomorphic adenomas slowly gain malignant characteristics after repeated recurrences.

          Related collections

          Most cited references27

          • Record: found
          • Abstract: found
          • Article: not found

          Recurrent pleomorphic adenoma of the parotid gland: report of 126 cases and a review of the literature.

          The records of 126 patients with recurrent pleomorphic adenoma of the parotid gland treated at our institution from 1965 to 1985 were retrospectively reviewed. Multiple variables were analyzed to determine tumor behavior and treatment results. Of the study patients, 61% were female and 39% male, with a mean age of 35.6 years at the time of treatment at our institution. The average follow-up period was 14.5 years. Tumor recurrence was 32.5% after one operation at our institution, 7.1% after two operations, and 1.6% after three. Malignant disease occurred in 9 (7.1%) patients. After all surgical procedures, partial facial nerve paralysis was noted in 13.5% and total paralysis in 5.5%. These results suggest low morbidity and good success in tumor eradication with an aggressive surgical approach.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Expression of estrogen receptor, progesterone receptor, and insulin-like growth factor receptor-1 and of MIB-1 in patients with recurrent pleomorphic adenoma of the parotid gland.

            Patients with recurrent pleomorphic adenomas of the parotid gland are difficult to manage without considerable risk of facial nerve injury. The prognostic significance of progesterone receptor (PR) and estrogen receptor (ER) reported in these adenomas was evaluated in patients with recurrent pleomorphic adenomas, comparing the results in a group of patients with primary adenomas without recurrences during 10 years of follow-up. Paraffin embedded tumor samples from 52 patients with recurrent pleomorphic adenoma of the parotid gland were collected and stained immunohistochemically. Expression of PR, ER, Ki-67 antigen, and insulin-like growth factor receptor-1 (IGFR-1) was analyzed in resected samples of recurrent tumors and was compared with samples from a control group of patients with primary pleomorphic adenoma. A difference (P < 0.05) in the type of tumor was observed between the recurrent group (more cell-poor variants) and the control group. ER expression was low in both groups (19% and 17%, respectively), but immunoreactivity for ER was higher (48%) in normal parotid gland tissue. PR expression in the recurrent group (96%) was higher compared with PR expression in the control group (61%; P < 0.001). PR expression and IGFR-1 expression were correlated weakly (correlation coefficient = 0.660; P = 0.053) in the recurrent group. The expression of growth fraction (Ki-67 score) and IGFR-1 was similar in both groups but was more extensive compared with normal parotid gland tissue. PR seems to be a prognostic factor in recurrent pleomorphic adenoma of the parotid gland. The PR pathway can be considered a potential target for hormone treatment in patients with these recurrent adenomas. Copyright 2002 American Cancer Society.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Clinical aspects of tumors of the major salivary glands.

                Bookmark

                Author and article information

                Journal
                Clin Exp Otorhinolaryngol
                CEO
                Clinical and Experimental Otorhinolaryngology
                Korean Society of Otorhinolaryngology-Head and Neck Surgery
                1976-8710
                2005-0720
                December 2009
                31 December 2009
                : 2
                : 4
                : 193-197
                Affiliations
                Department of Otolaryngology-Head and Neck Surgery, Dankook University, Cheonan, Korea.
                [1 ]Department of Otorhinolaryngology, Seoul National University College of Medicine, Seoul, Korea.
                [2 ]Department of Otorhinolaryngology-Head and Neck Surgery, Dongguk University International Hospital, Goyang, Korea.
                Author notes
                Corresponding author: Myung-Whun Sung, MD, PhD. Department of Otorhinolaryngology, Seoul National University College of Medicine, 28 Yeongeon-dong, Jongno-gu, Seoul 110-744, Korea. Tel: +82-2-2072-2448, Fax: +82-2-745-2387, drmung@ 123456naver.com
                Article
                10.3342/ceo.2009.2.4.193
                2804095
                20072694
                fec04487-02d4-42d6-a4eb-0ecb871ca4f8
                Copyright © 2009 Korean Society of Otorhinolaryngology-Head and Neck Surgery

                This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 09 June 2009
                : 17 July 2009
                Categories
                Original Article

                Otolaryngology
                recurrence,pleomorphic adenoma,risk factor,parotid glancl
                Otolaryngology
                recurrence, pleomorphic adenoma, risk factor, parotid glancl

                Comments

                Comment on this article